Martin Welschof
Chief Executive Officer at BIOINVENT INTERNATIONAL AB
Net worth: 53 062 $ as of 2024-04-29
Network origin in Martin Welschof first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.
10
| Holding Company | Pharmaceuticals: Major | 10 |
University of Bielefeld
7
| College/University | Other Consumer Services | 7 |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.
7
| Holding Company | Biotechnology | 7 |
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway.
5
| Extinct | Miscellaneous Commercial Services | 5 |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark.
4
| Extinct | Pharmaceuticals: Major | 4 |
Axaron Bioscience AG
 Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Axaron Bioscience AG develops biotechnologies. The company is based in Heidelberg, Germany and has subsidiaries in Germany.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Welschof via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SYNAXON AG | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree Masters Business Admin | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Thüga AG
 Thüga AG Electric UtilitiesUtilities Thüga AG operates as a holding company with interests in the energy and water sectors. It provides consulting services with its technical know-how and market assessments to partner companies, as well as ensures the financial support of municipal enterprises. The company was founded by Theodor Weigel in November 1867 and is headquartered in Munich, Germany. | Electric Utilities | Director/Board Member | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| University of Sussex | College/University | Undergraduate Degree | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Undergraduate Degree Masters Business Admin | |
| University of Oslo | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Hannover | College/University | Undergraduate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| Norwegian University of Science & Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Bergen | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree Corporate Officer/Principal | |
| National & Kapodistrian University of Athens | College/University | Undergraduate Degree | |
| BI Norwegian Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Landschaftliche Brandkasse Hannover
 Landschaftliche Brandkasse Hannover Multi-Line InsuranceFinance Landschaftliche Brandkasse Hannover provides multiple insurance services. The private company is based in Hannover, Germany. and has subsidiaries in Germany. The CEO of the German company is Hermann Kasten. | Multi-Line Insurance | Director/Board Member | |
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Caerus Capital AS
 Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Medexis Biotech SA | Chief Executive Officer | ||
Gerolymatos International SA
 Gerolymatos International SA Pharmaceuticals: MajorHealth Technology Part of Alapis Holding Industrial & Commercial SA, Gerolymatos International SA is a Greek company that manufactures and distributes pharmaceutical products. The company is based in Kryoneri, Greece. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Pfizer AS
 Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
GeneSeque AS
 GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Medical Specialties | Chairman | |
| CASiGEN Pharma Ltd. | Founder | ||
Biovista, Inc.
 Biovista, Inc. Internet Software/ServicesTechnology Services Biovista, Inc. operates as an artificial intelligence platform to develop pipeline drugs. The firm offers drug repositioning, personalized medicine, drug de risking, clinical hold and pipeline services. The company was founded by Aris Persidis and Andreas Persidis and is headquartered in Charlottesville, VA. | Internet Software/Services | Corporate Officer/Principal | |
| Universidad del Rosario | College/University | Doctorate Degree | |
Birk Venture AS
 Birk Venture AS Investment ManagersFinance Birk Venture AS (Birk Venture) is an independent Scandinavian venture capital firm which was founded in 2010 by Hans Ivar Robinson. Based in Oslo, Norway, the firm focuses exclusively on the life science industry, utilizing their industry experience and international network to partner with young companies with significant growth prospects. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
Balter Medical AS
 Balter Medical AS Medical SpecialtiesHealth Technology Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway. | Medical Specialties | Chairman Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member General Counsel | |
| Hellenic Biotechnology Cluster | Founder | ||
| Zestagen AG | Founder | ||
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Founder Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
PD - Berater der öffentlichen Hand GmbH
 PD - Berater der öffentlichen Hand GmbH Miscellaneous Commercial ServicesCommercial Services PD - Berater der öffentlichen Hand GmbH is a business consulting private company based in Berlin, Germany. PD - Berater der öffentlichen Hand GmbH provides business consulting services. The German company was founded in 2016 and is led by CEOs Stéphane Beemelmans and Claus Wechselmann. | Miscellaneous Commercial Services | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member |
Statistics
International
| Norway | 21 |
| Germany | 8 |
| Netherlands | 5 |
| Greece | 5 |
| Switzerland | 4 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 222 |
| Corporate Officer/Principal | 87 |
| Chairman | 65 |
| Chief Executive Officer | 44 |
| Independent Dir/Board Member | 40 |
Most connected contacts
| Insiders | |
|---|---|
| Karoly Nikolich | 30 |
| Nanna Liebach Lüneborg | 29 |
| Dharminder Singh Chahal | 25 |
| Thomas O. Hecht | 24 |
| Bernd Seizinger | 23 |
| Leonard Kruimer | 22 |
| Vincent Ossipow | 22 |
| Arne Handeland | 19 |
| Erlend Petter Skagseth | 17 |
| Keith Graham McCullagh | 16 |
| Erik Esveld | 15 |
| Hans Johan Hekland | 15 |
| Richard Stuart Godfrey | 15 |
| Björn Cochlovius | 14 |
| Achim Kaufhold | 14 |
- Stock Market
- Insiders
- Martin Welschof
- Company connections